AH-101-CVD was granted from US FDA for clinical trial in Jan, 23,2020.
The application for IND to TFDA is ongoing in Apr, 2020.
|
|
|
|
![]() |
AH-101-CVD was granted from US FDA for clinical trial in Jan, 23,2020.
The application for IND to TFDA is ongoing in Apr, 2020.
|
|
|
|
![]() |